News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
260,851 Results
Type
Article (13576)
Company Profile (110)
Press Release (247165)
Section
Business (87978)
Career Advice (462)
Deals (15326)
Drug Delivery (63)
Drug Development (36527)
Employer Resources (49)
FDA (6261)
Job Trends (6183)
News (150058)
Policy (14008)
Tag
Academia (436)
Alliances (23084)
Alzheimer's disease (347)
Approvals (6252)
Artificial intelligence (58)
Bankruptcy (143)
Best Places to Work (4307)
Biosimilars (39)
Biotechnology (44)
Breast cancer (38)
Cancer (284)
Career advice (406)
Cell therapy (39)
Clinical research (30324)
Collaboration (129)
Compensation (55)
COVID-19 (748)
C-suite (49)
Data (290)
Diabetes (47)
Diagnostics (1230)
Drug pricing (56)
Earnings (31454)
Employer resources (43)
Events (36651)
Executive appointments (145)
FDA (6424)
Funding (90)
Gene therapy (58)
GLP-1 (287)
Government (1264)
Healthcare (3520)
Infectious disease (765)
Inflammatory bowel disease (45)
Interviews (58)
IPO (5808)
Job creations (2049)
Job search strategy (373)
Layoffs (166)
Legal (3410)
Lung cancer (44)
Manufacturing (85)
Medical device (1264)
Medtech (1266)
Mergers & acquisitions (9537)
Metabolic disorders (154)
Neuroscience (436)
NextGen Class of 2024 (1581)
Non-profit (589)
Northern California (388)
Obesity (96)
Opinion (108)
Patents (51)
People (28423)
Pharmaceutical (64)
Phase I (7886)
Phase II (12821)
Phase III (11526)
Pipeline (134)
Podcasts (39)
Policy (43)
Postmarket research (1399)
Preclinical (3161)
Radiopharmaceuticals (116)
Rare diseases (82)
Real estate (2629)
Regulatory (9801)
Research institute (563)
Resumes & cover letters (56)
Southern California (398)
Startups (1625)
United States (3892)
Vaccines (109)
Weight loss (76)
Date
Today (76)
Last 7 days (321)
Last 30 days (1080)
Last 365 days (12738)
2024 (11083)
2023 (14247)
2022 (19562)
2021 (20076)
2020 (19039)
2019 (14901)
2018 (11718)
2017 (13889)
2016 (13129)
2015 (15472)
2014 (12420)
2013 (10593)
2012 (11395)
2011 (11922)
2010 (10889)
Location
Africa (313)
Arizona (39)
Asia (19754)
Australia (2553)
California (905)
Canada (559)
China (99)
Connecticut (37)
Europe (38700)
Florida (129)
Illinois (100)
Indiana (81)
Kansas (51)
Maryland (146)
Massachusetts (799)
Minnesota (50)
New Jersey (382)
New York (251)
North Carolina (269)
Northern California (388)
Pennsylvania (265)
South America (499)
Southern California (398)
Texas (121)
Virginia (37)
Washington State (66)
260,851 Results for "cipher pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cipher Pharmaceuticals Reports Third Quarter 2024 Results
November 7, 2024
·
16 min read
Press Releases
Cipher Pharmaceuticals Schedules Q3 2024 Earnings Release and Conference Call
November 5, 2024
·
1 min read
Press Releases
Cipher Pharmaceuticals Enhances Leadership Team with Appointment of New Chief Business Officer
October 8, 2024
·
6 min read
Business
Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference
Mississauga, Ontario--(Newsfile Corp. - April 3, 2024) - Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre.
April 3, 2024
·
2 min read
Business
Cipher Pharmaceuticals Reports Second Quarter 2024 Results
August 8, 2024
·
17 min read
Drug Development
Cipher Pharmaceuticals Partner Moberg Pharma AB Provides Update on MOB-015 Phase 3 Study
September 13, 2024
·
6 min read
Business
Cipher Pharmaceuticals Schedules Q2 2024 Earnings Release and Conference Call
August 1, 2024
·
1 min read
Press Releases
Cipher Pharmaceuticals Acquires Profitable Growth Dermatology Products from ParaPRO for US$89.5 Million
July 29, 2024
·
11 min read
Business
Cipher Surgical Announces Mark Alley as Chief Executive Officer (CEO)
Cipher Surgical, a leading innovator in medical device technology, is pleased to announce a strategic leadership transition effective March 4, 2024.
March 4, 2024
·
2 min read
Cipher Pharmaceuticals to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
Cipher Pharmaceuticals (TSX: CPH), a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, will be participating in the 2023 Bloom Burton & Co. Healthcare Investor
April 18, 2023
·
2 min read
1 of 26,086
Next
